Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The EARLY Validation and Utility of Somatic Symptom Scale CHINA for Assessing Somatic Symptom Disorder in MYOcardial Outpatients of General Hospital (EARLY-MYO-SSS-CN)

NCT03513185 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT03513185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03513185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The EARLY Validation and Utility of Somatic Symptom Scale CHINA for Assessing Somatic Symptom Disorder in MYOcardial Outpatients of General Hospital (EARLY-MYO-SSS-CN)
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Completed
Start date
September 1, 2017
Completion date
December 30, 2021
Enrollment
1,863 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

somatization disorder